Brief validation of the novel GeneXpert Xpress SARS-CoV-2 PCR assay

被引:34
|
作者
Goldenberger, Daniel [1 ,2 ]
Leuzinger, Karoline [3 ]
Sogaard, Kirstine K. [1 ,2 ,4 ]
Gosert, Rainer [3 ]
Roloff, Tim [1 ,2 ,4 ]
Naegele, Klaudia [3 ]
Cuenod, Aline [4 ]
Mari, Alfredo [4 ]
Seth-Smith, Helena [1 ,2 ,4 ]
Rentsch, Katharina [5 ]
Hinic, Vladimira [1 ,2 ]
Hirsch, Hans H. [3 ,6 ,7 ]
Egli, Adrian [1 ,2 ,4 ]
机构
[1] Univ Hosp Basel, Lab Med, Clin Bacteriol & Mycol, Basel, Switzerland
[2] Univ Basel, Basel, Switzerland
[3] Univ Hosp Basel, Lab Med, Clin Virol, Basel, Switzerland
[4] Univ Basel, Dept Biomed, Lab Med, Appl Microbiol Res, Basel, Switzerland
[5] Univ Hosp Basel, Lab Med, Basel, Switzerland
[6] Univ Hosp Basel, Infect Dis & Hosp Epidemiol, Basel, Switzerland
[7] Univ Basel, Dept Biomed, Transplantat & Clin Virol, Basel, Switzerland
关键词
SARS-CoV-2; COVID-19; GeneXpert; Respiratory infection; Viruses; Diagnostics; PCR; NAT; COBAS; 6800;
D O I
10.1016/j.jviromet.2020.113925
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The clinical and epidemiologic management of the SARS-CoV-2 pandemic is critically dependent on molecular assays with short turn-around time. We validated the novel Xpert Xpress SARS-CoV-2 assay using a commercial nucleic acid testing (Roche Cobas 6800). We found an excellent concordance over a range of SARS-CoV-2 loads and across established human coronaviruses.
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2
    McCormick-Baw, Clare
    Morgan, Kristi
    Gaffney, Donna
    Cazares, Yareli
    Jaworski, Karen
    Byrd, Adrienne
    Molberg, Kyle
    Cavuoti, Dominick
    JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (08)
  • [42] Performance evaluation of the cobas SARS-CoV-2 Duo, a novel qualitative and quantitative assay, for the detection of SARS-CoV-2 RNA
    Su, Yang-Di
    Lai, Chih-Cheng
    Lin, Tsai-Hsiu
    Chen, Wei-Cheng
    Hsueh, Po-Ren
    MICROBIOLOGY SPECTRUM, 2023, 11 (06):
  • [43] Comparative evaluation of the Thermo fisher TaqPath™ COVID-19 combo kit with the Cepheid Xpert® Xpress SARS-CoV-2 assay for detecting SARS-CoV-2 in nasopharyngeal specimens
    Granato, Paul A.
    Kimball, Simon R.
    Alkins, Brenda R.
    Cross, Deirdre C.
    Unz, Melissa M.
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [44] Performance of the LIAISON(R) SARS-CoV-2 Antigen Assay vs. SARS-CoV-2-RT-PCR
    Fiedler, Melanie
    Holtkamp, Caroline
    Dittmer, Ulf
    Anastasiou, Olympia E.
    PATHOGENS, 2021, 10 (06):
  • [45] Multi -center evaluation of cepheid xpert ? xpress SARS-CoV-2 point -of -care test during the SARS-CoV-2 pandemic
    Wolters, Femke
    van de Bovenkamp, Jeroen
    van den Bosch, Bart
    van den Brink, Sharon
    Broeders, Maaike
    Chung, Ngoc Hoa
    Favie, Barbara
    Goderski, Gabriel
    Kuijpers, Judith
    Overdevest, Ilse
    Rahamat-Langedoen, Janette
    Wijsman, Lisa
    Melchers, Willem Jg
    Meijer, Adam
    JOURNAL OF CLINICAL VIROLOGY, 2020, 128
  • [46] Coronaviruses and SARS-CoV-2: A Brief Overview
    Ludwig, Stephan
    Zarbock, Alexander
    ANESTHESIA AND ANALGESIA, 2020, 131 (01): : 93 - 96
  • [47] Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 test for bronchoalveolar lavage
    Phan, Tung
    Mays, Ashley
    McCullough, Melissa
    Wells, Alan
    JOURNAL OF CLINICAL VIROLOGY PLUS, 2022, 2 (02):
  • [48] Comparative evaluation of the Thermo fisher TaqPath™ COVID-19 combo kit with the Cepheid Xpert® Xpress SARS-CoV-2 assay for detecting SARS-CoV-2 in nasopharyngeal specimens
    Paul A. Granato
    Simon R. Kimball
    Brenda R. Alkins
    Deirdre C. Cross
    Melissa M. Unz
    BMC Infectious Diseases, 21
  • [49] Clinical Validation of a SARS-CoV-2 Real-Time Reverse Transcription PCR Assay Targeting the Nucleocapsid Gene
    SoRelle, Jeffrey A.
    Frame, Ithiel
    Falcon, Alejandra
    Jacob, Jerin
    Wagenfuehr, Jennifer
    Mitui, Midori
    Park, Jason Y.
    Filkins, Laura
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2020, 5 (05): : 889 - 896
  • [50] The increased sensitivity of the Xpert® Xpress assay in detecting SARS-COV-2, compared to the COBAS® assay, can be attributed to the nucleocapsid gene target
    Ayano, B.
    Alemu, A.
    Gebre-Selassie, S.
    Kebede, H.
    Abegaz, W.
    CLINICA CHIMICA ACTA, 2024, 558 : 28 - 28